The Benefit of Functional Movement Control for Patients With Knee Osteoarthritis

August 26, 2018 updated by: National Yang Ming University

The Benefit of Increasing Physical Activity and Functional Movement Control for Patients With Stage II or III Knee Osteoarthritis

The study purpose is to explore the effect of functional movement control for patients who have stage II or III degenerative knee joint disease and also physical inactive. Half of patients will receive aerobic exercise and functional movement control training in combination, while the other will simply receive aerobic exercise.

Study Overview

Detailed Description

Physical inactivity, which is a common phenomenon among patients with degenerative knee joint disease has been proved a predictor of increased symptoms and poor general health. However, changing the lifestyle of people with this disease who is physical inactive is still a problem which has not been solved. Knee pain may act as barrier to engage in physical activity and can influence patient's movement performance.

The different effectiveness between the aerobic exercise and functional movement control training.

Aerobic exercise has been proved could improve knee pain for the patients with degenerative knee joint disease.

The functional movement control training could improve knee alignment during walking and other functional activities to increase patient's movement awareness.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • New Taipei City, Taiwan
        • Recruiting
        • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
        • Sub-Investigator:
          • Shuo-Suei Hung, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participant who was diagnosed has knee osteoarthritis
  • Above 40 years old
  • Participant who didn't achieve at least 150 min moderate intensity physical activity level per week

Exclusion Criteria:

  • Patients with walking disability
  • Cannot complete 8 weeks intervention program
  • Received arthroscopy or other surgery before 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic exercise & movement control

The duration of intervention is 8 weeks.

  • Individualized functional movement control training is 60 min/week
  • Aerobic exercise is 60 min/week

The aerobic exercise content is no different between the experimental group and the active comparator group.

The movement control is individual training which divided into fourths progressing sessions.

  • First, lumbo-pelvic and hip dynamic direction control.
  • Second, trunk muscle groups, hip muscle groups and thigh muscle groups extensibility control.
  • Third, trunk muscle groups and hip muscle groups through range control.
  • Fourth, functional movement control training
Active Comparator: Aerobic exercise

The duration of intervention is 8 weeks.

  • Frequency: 2 times/ week
  • Duration: 60min/ time

The aerobic exercise will organized in groups. Each group has 6-8 persons. The exercise form is fixed at each time.

The description of exercise form is as below:

  • 10 min Warm up
  • 40 min Aerobic exercise (which focus on lower extremity muscle strengthening and increasing muscle endurance)
  • 10 min Cool down

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reaching proportions of the level of health enhancing physical activity
Time Frame: up to 6 months after intervention
the recommended level of health enhancing physical activity is at least 150 min of moderate intensity physical activity per week
up to 6 months after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Partial foot pressure as a percentage of body weight
Time Frame: Baseline and up to 1 week after intervention
The area footprinted during gait was divided into 6 parts according to the average foot areas of subject. Then, the partial foot pressure as a percentage of body weight was calculated as the average value during the stance phase of each step in each part as a percentage of the body weight.
Baseline and up to 1 week after intervention
Partial foot area as a percentage of body mass index
Time Frame: Baseline and up to 1 week after intervention
The area footprinted during gait was divided into 6 parts. The partial foot area as a percentage of body mass index was calculated as the average value during the stance phase of each step in each part as a percentage of the body mass index.
Baseline and up to 1 week after intervention
Gait Cadence
Time Frame: Baseline and up to 1 week after intervention
the number of steps per minute
Baseline and up to 1 week after intervention
Walking speed
Time Frame: Baseline and up to 1 week after intervention
the velocity of single step
Baseline and up to 1 week after intervention
Single leg stance time
Time Frame: Baseline and up to 1 week after intervention
the time of the stance phase of each foot
Baseline and up to 1 week after intervention
Step length
Time Frame: Baseline and up to 1 week after intervention
the distance between the first point of contact of a limb with the ground and the first point of contact of the limb on the opposite side
Baseline and up to 1 week after intervention
Step width
Time Frame: Baseline and up to 1 week after intervention
the distance between the centre of the first heel contact and the following one calculated perpendicularly to the direction of the horizontal axis drawn between the feet
Baseline and up to 1 week after intervention
Axis angle
Time Frame: Baseline and up to 1 week after intervention
the angle formed by the medial tangent of the foot and the line from the second/third toe to the center of the heel
Baseline and up to 1 week after intervention
The Knee injury and Osteoarthritis Outcome Score
Time Frame: Baseline and up to 1 week after intervention
A questionnaire to assess the patient's opinion about their knee and associated problems.
Baseline and up to 1 week after intervention
Sort Form-12v2 Healthy Survey
Time Frame: Baseline and 1, 3, 6 month after intervention
12 question to measure functional health and well-being from the patient's point of view
Baseline and 1, 3, 6 month after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Anticipated)

December 31, 2018

Study Completion (Anticipated)

December 31, 2018

Study Registration Dates

First Submitted

January 28, 2018

First Submitted That Met QC Criteria

February 12, 2018

First Posted (Actual)

February 13, 2018

Study Record Updates

Last Update Posted (Actual)

August 28, 2018

Last Update Submitted That Met QC Criteria

August 26, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Aerobic exercise & movement control

Subscribe